Pharmacogenomics of response to interferon-beta and glatiramer acetate in Multiple Sclerosis: A multi-centric study

Andrea Corona, Ferdinando Clarelli, Kimmo Pääkkönen, Adil Harroud, Klementy Shchetynsky, Alen Zollo, Alessandra Mingione, Melissa Sorosina, Elisabetta Mascia, Antonino Giordano, Maria Assunta Rocca, Fredrik Piehl, Pernilla Stridh, Bernhard Hemmer, An Goris, Bénédicte Dubois, Helle Bach Søndergaard, Finn Sellebjerg, Sandra D, Hanne Flinstad Harbo, Tomas Olsson, Janna Saarela, Alberto Priori, Massimo Filippi, Ingrid Kockum, Federica Esposito, Filippo Martinelli Boneschi

Multiple Sclerosis Journal

Published online on March 04, 2026

Abstract

Multiple Sclerosis Journal, Ahead of Print.
Background:Multiple sclerosis (MS) treatment response varies significantly, hindering effective management and necessitating better predictive biomarkers. Pharmacogenomics offers a promising avenue to identify genetic markers that, combined with clinico-...